Phase II Study of Preoperative Helical Tomotherapy for Rectal Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 3, 2008, Pages 728-734

  De Ridder, Mark ^a   Tournel, Koen ^a   Van Nieuwenhove, Yves ^a   Engels, Benedikt ^a   Hoorens, Anne ^a   Everaert, Hendrik ^a   Op de Beeck, Bart ^a   Vinh Hung, Vincent ^a   De Grève, Jacques ^a   Delvaux, Georges ^a   Verellen, Dirk ^a   Storme, Guy A ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Helical tomotherapy; Intensity modulated radiotherapy; Preoperative radiotherapy; Rectal cancer; Simultaneous integrated boost

Indexed keywords

DOSIMETRY; MAGNETIC RESONANCE IMAGING; METABOLISM; POSITRON EMISSION TOMOGRAPHY; TOXICITY; TUMORS;

HELICAL TOMOTHERAPY; INTENSITY MODULATED RADIOTHERAPY; PREOPERATIVE RADIOTHERAPY; RECTAL CANCER; SIMULTANEOUS INTEGRATED BOOST;

RADIOTHERAPY;

FLUORODEOXYGLUCOSE F 18;

ACUTE TOXICITY; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; ENTERITIS; FEMALE; GASTROINTESTINAL TOXICITY; HELICAL TOMOGRAPHY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECTUM CANCER; RECTUM RESECTION; SKIN TOXICITY; SMALL INTESTINE; TOMOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 38849091392     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.07.2332     Document Type: Article

References (34)

1. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
2. Nagtegaal I.D., Marijnen C.A., Kranenbarg E.K., et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: Not one millimeter but two millimeters is the limit. Am J Surg Pathol 26 (2002) 350-357
3. Marijnen C.A., Nagtegaal I.D., Kapiteijn E., et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55 (2003) 1311-1320
4. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264 (1990) 1444-1450
5. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
6. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
7. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
8. Fakih M.G., Rajput A., Yang G.Y., et al. A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 1462-1470
9. Rodel C., Liersch T., Hermann R.M., et al. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol 25 (2007) 110-117
10. Hofheinz R.D., Horisberger K., Woernle C., et al. Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer. Int J Radiat Oncol Biol Phys 66 (2006) 1384-1390
11. Minsky B.D. Combined modality therapy of resectable rectal cancer: Current approaches. Tech Coloproctol 8 (2004) 67-76
12. Gambacorta M.A., Valentini V., Coco C., et al. Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of Stage II-III resectable rectal cancer: Phase I and II studies. Int J Radiat Oncol Biol Phys 60 (2004) 139-148
13. Beavis A.W. Is tomotherapy the future of IMRT?. Br J Radiol 77 (2004) 285-295
14. MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY Study. Radiology 243 (2007) 132-139
15. Belgian Procare Workgroup. Multidisciplinary guidelines for the treatment of rectal cancer. Available at: www.belsurg.org. Accessed February 10, 2006.
16. Baglan K.L., Frazier R.C., Yan D., et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 52 (2002) 176-183
17. Kissick M.W., Fenwick J., James J.A., et al. The helical tomotherapy thread effect. Med Phys 32 (2005) 1414-1423
18. Amthauer H., Denecke T., Rau B., et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 31 (2004) 811-819
19. MacFarlane J.K., Ryall R.D., and Heald R.J. Mesorectal excision for rectal cancer. Lancet 341 (1993) 457-460
20. Compton C.C., Fielding L.P., Burgart L.J., et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124 (2000) 979-994
21. Nagtegaal I.D., and van Krieken J.H. The role of pathologists in the quality control of diagnosis and treatment of rectal cancer-An overview. Eur J Cancer 38 (2002) 964-972
22. Marr R., Birbeck K., Garvican J., et al. The modern abdominoperineal excision: The next challenge after total mesorectal excision. Ann Surg 242 (2005) 74-82
23. Gerard J.P., Chapet O., Nemoz C., et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial. J Clin Oncol 22 (2004) 2404-2409
24. Crane C.H., Skibber J.M., Birnbaum E.H., et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 57 (2003) 84-89
25. Minsky B.D., Conti J.A., Huang Y., et al. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 13 (1995) 1409-1416
26. Letschert J.G., Lebesque J.V., de Boer R.W., et al. Dose-volume correlation in radiation-related late small-bowel complications: A clinical study. Radiother Oncol 18 (1990) 307-320
27. Grann A., Minsky B.D., Cohen A.M., et al. Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer. Dis Colon Rectum 40 (1997) 515-522
28. Hyams D.M., Mamounas E.P., Petrelli N., et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: A progress report of National Surgical Breast and Bowel Project Protocol R-03. Dis Colon Rectum 40 (1997) 131-139
29. Birgisson H., Pahlman L., Gunnarsson U., et al. Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23 (2005) 8697-8705
30. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
31. Guerrero Urbano M.T., Henrys A.J., Adams E.J., et al. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 65 (2006) 907-916
32. Duthoy W., De Gersem W., Vergote K., et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys 60 (2004) 794-806
33. Buchholz D.J., Lepek K.J., Rich T.A., et al. 5-Fluorouracil-radiation interactions in human colon adenocarcinoma cells. Int J Radiat Oncol Biol Phys 32 (1995) 1053-1058
34. Guillem J.G., Moore H.G., Akhurst T., et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: A means for determining long-term outcomes of rectal cancer. J Am Coll Surg 199 (2004) 1-7